Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking

Archives of Pharmacal Research

Volumn 34, Issue 3, 2011, Pages 495-500

  Kim, Junghyun ^a   Jeong, Il Ha ^a   Kim, Chan Sik ^a   Lee, Yun Mi ^a   Kim, Jong Min ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Advanced glycation end products; Chlorogenic acid; Diabetic complications; Methylglyoxal

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; BOVINE SERUM ALBUMIN; CHLOROGENIC ACID; COLLAGEN; GLUCOSE; METHYLGLYOXAL;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERGLYCEMIA; IC 50; IN VITRO STUDY; INHIBITION KINETICS; PROTEIN CROSS LINKING;

ANIMALS; CATTLE; CHLOROGENIC ACID; COLLAGEN; CROSS-LINKING REAGENTS; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; PROTEIN BINDING; PROTEIN CARBONYLATION; RATS; SERUM ALBUMIN, BOVINE; TENDONS;

EID: 79959964198     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0319-5     Document Type: Article

References (37)

1. Andrade-Cetto, A. and Wiedenfeld, H., Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J. Ethnopharmacol., 78, 145-149 (2001). (Pubitemid 32994783)
2. Baynes, J. W. and Thorpe, S. R., Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48, 1-9 (1999). (Pubitemid 29019345)
3. Bourajjaj, M., Stehouwer, C. D., Van Hinsbergh, V. W., and Schalkwijk, C. G., Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem. Soc. Trans., 31, 1400-1402 (2003). (Pubitemid 38030985)
4. Brownlee, M., Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med., 46, 223-234 (1995).
5. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820 (2001). (Pubitemid 34000785)
6. Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., and Baynes, J. W., Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int., 61, 939-950 (2002). (Pubitemid 34175462)
7. Edelstein, D. and Brownlee, M., Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes, 41, 26-29 (1992).
8. Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G., and Cooper, M. E., Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia, 44, 108-114 (2001). (Pubitemid 32141892)
9. Gugliucci, A., Bastos, D. H., Schulze, J., and Souza, M. F., Caffeic and chlorogenic acids in Ilex paraguariensis extracts are the main inhibitors of AGE generation by methylglyoxal in model proteins. Fitoterapia, 80, 339-344 (2009).
10. Haik, G. M., Jr., Lo, T. W., and Thornalley, P. J., Methylglyoxal concentration and glyoxalase activities in the human lens. Exp. Eye Res., 59, 497-500 (1994). (Pubitemid 24352084)
11. Herrera-Arellano, A., Aguilar-Santamaria, L., Garcia- Hernandez, B., Nicasio-Torres, P., and Tortoriello, J., Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. Phytomedicine, 11, 561-566 (2004). (Pubitemid 40007737)
12. Jang, D. S., Yoo, N. H., Lee, Y. M., Yoo, J. L., Kim, Y. S., and Kim, J. S., Constituents of the flowers of Erigeron annuus with inhibitory activity on the formation of advanced glycation end products (AGEs) and aldose reductase. Arch. Pharm. Res., 31, 900-904 (2008).
13. Kiho, T., Usui, S., Hirano, K., Aizawa, K., and Inakuma, T., Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci. Biotechnol. Biochem., 68, 200-205 (2004). (Pubitemid 39251584)
14. Kono, Y., Kashine, S., Yoneyama, T., Sakamoto, Y., Matsui, Y., and Shibata, H., Iron chelation by chlorogenic acid as a natural antioxidant. Biosci. Biotechnol. Biochem., 62, 22-27 (1998). (Pubitemid 128475017)
15. Lo, T. W., Selwood, T., and Thornalley, P. J., The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem. Pharmacol., 48, 1865-1870 (1994). (Pubitemid 24355014)
16. Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P., and Munch, G., Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur. J. Biochem., 267, 4171-4178 (2000). (Pubitemid 30436113)
17. Miyata, T., Wada, Y., Cai, Z., Iida, Y., Horie, K., Yasuda, Y., Maeda, K., Kurokawa, K., and Van Ypersele De Strihou, C., Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int., 51, 1170-1181 (1997). (Pubitemid 27186543)
18. Nagaraj, R. H., Sarkar, P., Mally, A., Biemel, K. M., Lederer, M. O., and Padayatti, P. S., Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch. Biochem. Biophys., 402, 110-119 (2002). (Pubitemid 34848300)
19. Osawa, T. and Kato, Y., Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann. N. Y. Acad. Sci., 1043, 440-451 (2005). (Pubitemid 41123932)
20. Pokupec, R., Kalauz, M., Turk, N., and Turk, Z., Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses. Graefes Arch. Clin. Exp. Ophthalmol., 241, 378-384 (2003). (Pubitemid 36748573)
21. Price, D. L., Rhett, P. M., Thorpe, S. R., and Baynes, J. W., Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem., 276, 48967-48972 (2001).
22. Rodriguez De Sotillo, D. V. and Hadley, M., Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem., 13, 717-726 (2002). (Pubitemid 35463200)
23. Sato, T., Iwaki, M., Shimogaito, N., Wu, X., Yamagishi, S., and Takeuchi, M., TAGE (toxic AGEs) theory in diabetic complications. Curr. Mol. Med., 6, 351-358 (2006).
24. Sensi, M., Pricci, F., Andreani, D., and Di Mario, U., Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res., 16, 1-9 (1991).
25. Shamsi, F. A., Partal, A., Sady, C., Glomb, M. A., and Nagaraj, R. H., Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes. J. Biol. Chem., 273, 6928-6936 (1998). (Pubitemid 28160358)
26. Singh, R., Barden, A., Mori, T., and Beilin, L., Advanced glycation end-products: a review. Diabetologia, 44, 129-146 (2001). (Pubitemid 32156196)
27. Sohn, E., Kim, J., Kim, C. S., Kim, Y. S., Jang, D. S., and Kim, J. S., Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via antiapoptosis of podocytes in streptozotocin-induced diabetic rats. Biochem. Biophys. Res. Commun., 391, 733-738 (2010).
28. Stitt, A., Gardiner, T. A., Alderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., and Thorpe, S. R., The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes, 51, 2826-2832 (2002). (Pubitemid 34970937)
29. Stitt, A. W., The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp. Mol. Pathol., 75, 95-108 (2003). (Pubitemid 36798117)
30. Svilaas, A., Sakhi, A. K., Andersen, L. F., Svilaas, T., Strom, E. C., Jacobs, D. R., Jr., Ose, L., and Blomhoff, R., Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J. Nutr., 134, 562-567 (2004). (Pubitemid 38298496)
31. Thornalley, P. J., Langborg, A., and Minhas, H. S., Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J., 344 Pt 1, 109-116 (1999).
32. Thornalley, P. J., Yurek-George, A., and Argirov, O. K., Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol., 60, 55-65 (2000). (Pubitemid 30243085)
33. Van Dam, R. M. and Feskens, E. J., Coffee consumption and risk of type 2 diabetes mellitus. Lancet, 360, 1477-1478 (2002). (Pubitemid 35356327)
34. Vasan, S., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., Bucala, R., Cerami, A., Egan, J., and Ulrich, P., An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature, 382, 275-278 (1996). (Pubitemid 26251366)
35. Vinson, J. A. and Howard III, T. B., Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem., 7, 659-663 (1996). (Pubitemid 27019421)
36. Wolff, S. P., Bascal, Z. A., and Hunt, J. V., Autoxidative glycosylation: free radicals and glycation theory. Prog. Clin. Biol. Res., 304, 259-275 (1989).
37. Wolff, S. P., Jiang, Z. Y., and Hunt, J. V., Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic. Biol. Med., 10, 339-352 (1991). (Pubitemid 121003905)